162 related articles for article (PubMed ID: 22560885)
1. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
2. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
[TBL] [Abstract][Full Text] [Related]
3. Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
Syed Soffian SS; Safian N; Nawi AM; Ahmad SB; Chan HK; Abu Hassan MR
PLoS One; 2021; 16(10):e0258129. PubMed ID: 34618854
[TBL] [Abstract][Full Text] [Related]
4. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme.
Khuhaprema T; Sangrajrang S; Lalitwongsa S; Chokvanitphong V; Raunroadroong T; Ratanachu-Ek T; Muwonge R; Lucas E; Wild C; Sankaranarayanan R
BMJ Open; 2014 Jan; 4(1):e003671. PubMed ID: 24435889
[TBL] [Abstract][Full Text] [Related]
5. Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
Ibáñez-Sanz G; Milà N; Vidal C; Rocamora J; Moreno V; Sanz-Pamplona R; Garcia M;
PLoS One; 2021; 16(6):e0253369. PubMed ID: 34191813
[TBL] [Abstract][Full Text] [Related]
6. Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.
van der Vlugt M; Grobbee EJ; Bossuyt PM; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Essink-Bot ML; Spaander MC; Dekker E
Br J Cancer; 2017 Jan; 116(1):44-49. PubMed ID: 27923037
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the "Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing" (B-PREDICT)-a population-based colorectal cancer screening program.
Brezina S; Leeb G; Baierl A; Gräf E; Hackl M; Hofer P; Lang H; Klein M; Mach K; Schwarzer R; Wlassits W; Püspök A; Gsur A
BMC Gastroenterol; 2024 Apr; 24(1):149. PubMed ID: 38689217
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer population screening programs worldwide in 2016: An update.
Navarro M; Nicolas A; Ferrandez A; Lanas A
World J Gastroenterol; 2017 May; 23(20):3632-3642. PubMed ID: 28611516
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers.
Niv Y; Lev-El M; Fraser G; Abuksis G; Tamir A
Gut; 2002 Jan; 50(1):33-7. PubMed ID: 11772964
[TBL] [Abstract][Full Text] [Related]
10. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain).
Portillo I; Arana-Arri E; Idigoras I; Bilbao I; Martínez-Indart L; Bujanda L; Gutierrez-Ibarluzea I
World J Gastroenterol; 2017 Apr; 23(15):2731-2742. PubMed ID: 28487610
[TBL] [Abstract][Full Text] [Related]
11. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.
Hewitson P; Ward AM; Heneghan C; Halloran SP; Mant D
Br J Cancer; 2011 Aug; 105(4):475-80. PubMed ID: 21829202
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.
Salimzadeh H; Bishehsari F; Sauvaget C; Amani M; Hamzehloo G; Nikfarjam A; Merat S; Delavari A; Malekzadeh R
Arch Iran Med; 2017 Dec; 20(12):726-733. PubMed ID: 29664311
[TBL] [Abstract][Full Text] [Related]
13. The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis.
Ding H; Lin J; Xu Z; Wang HHX; Huang L; Huang J; Wong MCS
BMC Cancer; 2024 Mar; 24(1):365. PubMed ID: 38515013
[TBL] [Abstract][Full Text] [Related]
14. Can an alert in primary care electronic medical records increase participation in a population-based screening programme for colorectal cancer? COLO-ALERT, a randomised clinical trial.
Guiriguet-Capdevila C; Muñoz-Ortiz L; Rivero-Franco I; Vela-Vallespín C; Vilarrubí-Estrella M; Torres-Salinas M; Grau-Cano J; Burón-Pust A; Hernández-Rodríguez C; Fuentes-Peláez A; Reina-Rodríguez D; De León-Gallo R; Mendez-Boo L; Torán-Monserrat P
BMC Cancer; 2014 Mar; 14():232. PubMed ID: 24685117
[TBL] [Abstract][Full Text] [Related]
15. Invitation strategies and coverage in the population-based cancer screening programmes in the European Union.
Vale DB; Anttila A; Ponti A; Senore C; Sankaranaryanan R; Ronco G; Segnan N; Tomatis M; Žakelj MP; Elfström KM; Lönnberg S; Dillner J; Basu P
Eur J Cancer Prev; 2019 Mar; 28(2):131-140. PubMed ID: 29570103
[TBL] [Abstract][Full Text] [Related]
16. Hub-and-Spoke centralized intervention to optimize colorectal cancer screening and follow-up: A pragmatic, cluster-randomized controlled trial protocol.
Castañeda SF; Gupta S; Nodora JN; Largaespada V; Roesch SC; Rabin BA; Covin J; Ortwine K; Preciado-Hidalgo Y; Howard N; Halpern MT; Martinez ME
Contemp Clin Trials; 2023 Nov; 134():107353. PubMed ID: 37802222
[TBL] [Abstract][Full Text] [Related]
17. Can iFOBT (immunochemical faecal occult blood test) for bowel cancer screening be safely deferred for five years after a colonoscopy?
Khaing MM; Lin L; Rahman T; Peter-Kini G; Croese J; Hodgson R; Thomas J; Kellar P; Whittaker D; Hartnell F; Vandeleur A; Ea V; Boyd P
Clin Med (Lond); 2020 Mar; 20(Suppl 2):s90. PubMed ID: 32409399
[No Abstract] [Full Text] [Related]
18. Survey of colorectal cancer screening practices in a large Canadian urban centre.
Mack LA; Stuart H; Temple WJ
Can J Surg; 2004 Jun; 47(3):189-94. PubMed ID: 15264381
[TBL] [Abstract][Full Text] [Related]
19. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer.
Kaminski MF; Bretthauer M; Zauber AG; Kuipers EJ; Adami HO; van Ballegooijen M; Regula J; van Leerdam M; Stefansson T; Påhlman L; Dekker E; Hernán MA; Garborg K; Hoff G
Endoscopy; 2012 Jul; 44(7):695-702. PubMed ID: 22723185
[TBL] [Abstract][Full Text] [Related]
20. Colorectal Cancer Screening for Persons With a Positive Family History—Evaluation of the FARKOR Program for the Secondary Prevention of Colorectal Cancer in Persons Aged 25 to 50.
Crispin A; Rehms R; Hoffmann S; Lindoerfer D; Hallsson LR; Jahn B; Mühlberger N; Sroczynski G; Siebert U; Mansmann U
Dtsch Arztebl Int; 2023 Nov; 120(46):786-792. PubMed ID: 37855423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
